Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institut Català de Retina is a private ophthalmology group based in Barcelona, Spain, focused on the prevention, diagnosis, treatment, and long-term management of eye diseases and disorders of the visual system. The organization operates as an integrated medical and surgical eye-care provider, covering major ophthalmic subspecialties including retina and vitreous, cataract, refractive surgery, glaucoma, cornea, pediatric ophthalmology, oculoplastics, strabismus, and uveitis. It combines outpatient consultations, diagnostic testing, laser procedures, ophthalmic surgery, and 24/7 ophthalmic emergency care across multiple sites in Barcelona and Terrassa. Rather than being a drug-development biotech company, ICR is best characterized as a high-volume specialty healthcare provider with advanced ophthalmic technology, research, teaching, and commercial clinical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut Català de Retina.